

N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine
CAS No. 1071135-06-2
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine( —— )
Catalog No. M28592 CAS No. 1071135-06-2
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine is a novel 2,6-naphthyridine identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
![]() ![]() |
10MG | 444 | Get Quote |
![]() ![]() |
25MG | 711 | Get Quote |
![]() ![]() |
50MG | 1008 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameN-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine is a novel 2,6-naphthyridine identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor.
-
DescriptionN-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine is a novel 2,6-naphthyridine identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetSerine/threonin kinase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1071135-06-2
-
Formula Weight388.51
-
Molecular FormulaC23H28N6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CC1)CCC1Nc1nccc(-c2cc3cnccc3c(N3CCNCC3)n2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen CK, et al. The metabolism of 2-methyladenosine in Mycobacterium smegmatis. Microbiology (Reading). 2002 Jan;148(Pt 1):289-295.
molnova catalog



related products
-
CRT0066101 dihydroch...
CRT0066101 dihydrochloride is an inhibitor of PKD.
-
PCSK9-IN-10
PCSK9-IN-10, a potent and orally active inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), exhibits a half-maximal inhibitory concentration (IC50) of 6.4 μM.
-
BioE-1115
BioE-1115 is a selective and potent inhibitor of serine-threonine protein kinase (PASK, IC50 = 4 nM).